About me
Kristen Fortney is the co-founder and CEO of BioAge Labs, a clinical-stage biotechnology company developing a pipeline of treatments to treat metabolic diseases such as obesity by targeting the molecular causes of aging. The company uses its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human lifespan. Fortney’s scientific background is in aging biology and bioinformatics.